Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
Work
Year: 2001
Type: article
Abstract: Hairy-cell leukemia that is resistant to treatment with purine analogues, including cladribine, has a poor prognosis. We tested the safety and efficacy of an immunotoxin directed against a surface ant... more
Source: New England Journal of Medicine
Authors Robert J. Kreitman, Wyndham H. Wilson, Karen Bergeron, Miranda Raggio, Maryalice Stetler‐Stevenson +2 more
Institutions State Key Laboratory of Molecular Biology, MRC Laboratory of Molecular Biology, Cancer Institute (WIA)
Cites: 43
Cited by: 515
Related to: 10
FWCI: 12.88
Citation percentile (by year/subfield): 95.07
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze